...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Evaluation of Anti-Secretory and Anti-Ulcerogenic Activities of Avipattikar Churna on The Peptic Ulcers in Experimental Rats
【24h】

Evaluation of Anti-Secretory and Anti-Ulcerogenic Activities of Avipattikar Churna on The Peptic Ulcers in Experimental Rats

机译:Avipattikar Churna对实验性大鼠消化性溃疡的抗分泌和抗泌尿生殖活性的评估

获取原文

摘要

Background: Avipattikar churna, a poly-herbal formulation, is one of the popular ayurvedic formulations which is used for peptic ulcer diseases but the scientific documentation with regards to its effect for the indication is lacking.Aims: This study was carried out to evaluate the anti-secretory and the anti-ulcerogenic activities of the churna and to compare its activity with that of ranitidine in a pyloric ligated model of rats.Material and Methods: Four groups of rats with 6 animals in each served as the ulcer controls, churna low dose (500 mg/kg), churna high dose (750mg/kg) and ranitidine (25mg/kg). The control group rats received only vehicle (2% (v/v) gum acacia), while the rats of the other groups received the respective dose of the churna or ranitidine which was suspended in the vehicle. The treatments were given twice a day, orally, for two days. After 1 hour of the last dose, pyloric ligations were performed and the rats were sacrificed for evaluation after four hours of the ligations. The gastric contents were collected and its volume, pH and acidity were measured. The numbers of ulcers and their lengths were measured which were used to calculate the gastric irritancy index and the curative ratio. The histological examinations of the gastric tissues were also performed.Results: The churna, in both doses, significantly decreased the volumes of the gastric contents, the ulcer score, the length of the ulcer, the gastric irritancy index and pH increased as compared to those in the control group. The effects of the churna were comparable to that of ranitidine. The histopathological evaluation of the gastric tissue also supported the results.Conclusion: Avipattikar churna has anti-secretory and anti-ulcerogenic effects which are comparable to those of ranitidine in peptic ulcer diseases.
机译:背景:Avipattikar churna是一种多草药制剂,是一种流行的印度草药制剂,可用于消化性溃疡疾病,但尚缺乏有关其对适应症的作用的科学文献。目的:进行这项研究以评估材料和方法:四组大鼠,每组6只动物作为溃疡对照组,低剂量的hur鱼,以比较幽门结扎模型中model鱼的分泌和抗溃疡活性,并与雷尼替丁进行比较。剂量(500 mg / kg),大剂量高脂(750mg / kg)和雷尼替丁(25mg / kg)。对照组大鼠仅接受媒介物(2%(v / v)阿拉伯树胶),而其他组的大鼠则接受悬浮在媒介物中的相应剂量的秋葵或雷尼替丁。每天两次口服治疗,持续两天。在最后一次剂量的1小时后,进行幽门结扎,并在结扎4小时后处死大鼠以进行评估。收集胃内容物并测量其体积,pH和酸度。测量溃疡的数目和长度,以计算胃刺激指数和治愈率。结果:两种剂量的秋葵均显着降低了胃内容物的体积,溃疡评分,溃疡长度,胃刺激指数和pH,与之相比均明显降低。在对照组中。秋葵的作用与雷尼替丁相当。胃组织的组织病理学评估也支持该结果。结论:Avipattikar churna具有抗分泌和抗溃疡的作用,与雷尼替丁在消化性溃疡疾病中的作用相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号